Ureteral Neoplasms
Information
- Disease name
- Ureteral Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03288545 | Active, not recruiting | Phase 1/Phase 2 | A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer | October 11, 2017 | December 31, 2026 |
| NCT01328574 | Completed | Phase 2 | TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma | March 2011 | November 2014 |
| NCT00077688 | Completed | Phase 2 | TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium | November 2003 | September 2007 |
| NCT03219333 | Completed | Phase 2 | A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer | October 8, 2017 | July 28, 2023 |
| NCT05614739 | Recruiting | Phase 1 | A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | January 12, 2023 | June 2025 |
| NCT02607709 | Suspended | N/A | Lymphadenectomy in Urothelial Carcinoma | June 2016 | January 2024 |
| NCT02612194 | Terminated | Phase 2 | LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer | September 27, 2016 | November 21, 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014516